PUFXF - PUF Ventures Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.3476
+0.0396 (+12.86%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.3080
Open0.3228
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3182 - 0.3476
52 Week Range0.2746 - 1.8500
Volume42,938
Avg. Volume23,650
Market Cap20.947M
Beta1.33
PE Ratio (TTM)N/A
EPS (TTM)-0.0660
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PUF Ventures and Natures Hemp Applaud Health Canada Changes to Industrial Hemp Regulations
    CNW Group23 minutes ago

    PUF Ventures and Natures Hemp Applaud Health Canada Changes to Industrial Hemp Regulations

    VANCOUVER , Aug. 15, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (PU3.F) (PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Natures Hemp Corp., a biotechnology and consumer products company focused on unlocking the true value of the hemp for both B2B and B2C markets, commend Health Canada for the recent changes to Industrial Hemp Regulations and specifically the publication of the Subsection 56(1) Class Exemption in relation to the use of hemp under industrial hemp regulations (flowering heads, leaves and branches). "Natures Hemp is developing nutrient rich cannabidiol (CBD) food, beverage and healthcare related products and we support any move to lessen the restrictions surrounding industrial hemp production," said Derek Ivany , President and CEO of PUF Ventures Inc. "With the legalization of cannabis in Canada on October 17, 2018 , the changes are timely to allow hemp cultivators use the whole plant with their next harvest.

  • PUF Ventures Announces the Court Approval of the Plan of Arrangement and Closing of First Tranche of $0.25 Special Warrant Private Placement
    CNW Groupyesterday

    PUF Ventures Announces the Court Approval of the Plan of Arrangement and Closing of First Tranche of $0.25 Special Warrant Private Placement

    PUF Ventures Announces the Court Approval of the Plan of Arrangement and Closing of First Tranche of $0.25 Special Warrant Private Placement

  • PUF Ventures Reports Special Meeting Results
    CNW Group7 days ago

    PUF Ventures Reports Special Meeting Results

    PUF Ventures Reports Special Meeting Results

  • PUF Ventures Inc. Announces Update to Natures Hemp Special Warrant Financing
    CNW Group12 days ago

    PUF Ventures Inc. Announces Update to Natures Hemp Special Warrant Financing

    VANCOUVER , Aug. 3, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (PUF.CN) (PU3.F) (PUFXF), announces that, further to its information circular dated June 18, 2018 (the "Circular"), the Company wishes to provide an update on Natures Hemp Corp. ("Natures Hemp") special warrant financing to raise gross proceeds of up to $5,000,000 at a price of $0.25 per special warrant (the " $0.25 Financing"). The Circular detailing the plan of arrangement indicated that Natures Hemp planned to complete the $0.25 Financing on or before July 31, 2018 .

  • GlobeNewswire15 days ago

    PUF Ventures Bringing Science of Plant Propagation to Medical and Recreational Cannabis Industry

    In an effort to differentiate itself from the emerging cannabis market in Canada, PUF Ventures Inc. (PUFXF) (PUF.CN) (PU3.F) has taken a novel approach to producing cannabis that should prove to be every bit as lucrative as growing it.  With the idea of separating itself from the competition, the innovative Vancouver-based company partnered with Casey Houweling, who has 4 decades of experience with plant propagation, to form Propagation Services Canada Inc. (PSC), to introduce the concept of science-based vegetative propagation to the cannabis industry in Canada. With the federal government in Canada passing Bill C-45 or the “Cannabis Act” and recreational cannabis becoming legal on October 17, 2018, the cannabis market in Canada has become an economic juggernaut.  PUF Ventures will use its third party propagation services to navigate the landscape there and develop what should be an operation with long-term success in the industry.

  • PUF Ventures Provides Update Regarding the Business of Natures Hemp Corp.
    CNW Group28 days ago

    PUF Ventures Provides Update Regarding the Business of Natures Hemp Corp.

    VANCOUVER , July 18, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (PU3.F) (PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update on the business of its subsidiary Natures Hemp Corp. ("Natures Hemp"). Natures Hemp, a biotechnology and consumer products company focused on unlocking the true value of the hemp for both B2B and B2C markets, and Cannvas MedTech Inc. ("Cannvas"), a leading business technology company within the cannabis space, are pleased to announce the signing of a letter of intent  (the "LOI"), to negotiate in good faith a data analytics agreement, for which Cannvas will provide industry insight and analytical modelling capabilities to Natures Hemp business models and Key Performance Indicators (KPIs).

  • PUF Ventures Engages Cannabis Compliance Inc. for Large-scale Greenhouse Facility in Delta, BC
    CNW Grouplast month

    PUF Ventures Engages Cannabis Compliance Inc. for Large-scale Greenhouse Facility in Delta, BC

    VANCOUVER , July 5, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (PU3.F) (PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that it has engaged Cannabis Compliance Inc. (CCI) to prepare the new Propagation Canada Services (PSC) cannabis propagation facility in Delta, BC . CCI has more than 10 years experience providing risk mitigation, due diligence and regulatory compliance to commercial cannabis producers and resellers worldwide. "We are very pleased to be working with the team at PUF, the Houwelings Group and the recently formed Propagation Services Canada, as they introduce large-scale propagation services to the cannabis sector," said Deepak Anand , Vice President of Business Development & Government Relations at Cannabis Compliance Inc. "This is one of the larger facilities that CCI has had the pleasure to work on and provide our regulatory expertise in preparation for Health Canada review.

  • PUF Ventures Brings Large-Scale Propagation to the Canadian Cannabis Industry - Existing 2.2 Million Sq. Ft. Facility Used to Propagate Flower Ready Cannabis Plants
    CNW Grouplast month

    PUF Ventures Brings Large-Scale Propagation to the Canadian Cannabis Industry - Existing 2.2 Million Sq. Ft. Facility Used to Propagate Flower Ready Cannabis Plants

    VANCOUVER , July 3, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (PU3.F) (PUFXF), is pleased to announce the science of plant propagation has arrived for the medical and recreational cannabis growers of Canada . On June 29, 2018 the Company announced the formation of Propagation Services Canada Inc. ("PSC") through a partnership with Casey Houweling . By outsourcing propagation services licensed producers of cannabis can significantly increase revenue while reducing the risk association to cloning cannabis plants.

  • PUF Ventures Inc. & Houweling's Group, form Propagation Services Canada Inc. within a 2.2 million sq. ft. existing facility
    CNW Group2 months ago

    PUF Ventures Inc. & Houweling's Group, form Propagation Services Canada Inc. within a 2.2 million sq. ft. existing facility

    VANCOUVER , June 29, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (PUF.CN) (PU3.F) (PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce the formation of Propagation Services Canada Inc. ("PSC") which will provide "flower ready" starter plants to Cannabis Cultivators in Canada and internationally. "Providing flower ready cannabis plants to cultivators is a natural evolution of the cannabis industry, following a similar path as the vegetable growing industry," said Casey Houweling .

  • PUF Ventures Inc. Signing of Arrangement Agreement
    CNW Group3 months ago

    PUF Ventures Inc. Signing of Arrangement Agreement

    The purpose of the Arrangement is to allow the Company to divest itself of the Assets to Natures Hemp, enabling the Company to focus on the cultivation and future sales of cannabis with both THC and CBD and other vertically integrated products concerning cannabis.  Natures Hemp will have a diversified management team, with special focus on hemp-related products, isolate extractions and related nutraceutical and medicinal products.

  • PUF Ventures Forms Colombian Subsidiary to Pursue International Opportunities
    CNW Group3 months ago

    PUF Ventures Forms Colombian Subsidiary to Pursue International Opportunities

    VANCOUVER , May 4, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (PU3.F) (PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce the formation of a wholly owned subsidiary Pure Grow Medicinals S.A.S. in Colombia to pursue additional international opportunities in the cannabis industry. " Colombia is in the early stages of legalizing cannabis for medicinal and export purposes, and represents a strategic opportunity for PUF" said Derek Ivany , President and CEO of the Company. Medical cannabis was formally legalized in Colombia in 2015.

  • Dr. Peter Tolias, PhD Joins PUF Ventures' Advisory Board
    CNW Group4 months ago

    Dr. Peter Tolias, PhD Joins PUF Ventures' Advisory Board

    Dr. Peter Tolias, PhD Joins PUF Ventures' Advisory Board

  • CNW Group4 months ago

    Australian Governments to Streamline Access to Medical Cannabis

    VANCOUVER , April 24, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (PU3.F) (PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce its full support of the Council of Australian Governments and their recent decision to significantly reduce the wait time for medical cannabis patients. The Council, made up of leaders from all states and territories of Australia , agreed to a national policy which will reduce the wait time for patients to access medical cannabis from months to days. "Patient access to medical cannabis is an important issue and we applaud the governments of Australia for reducing the wait times to access these important prescriptions," said Derek Ivany , President and CEO of PUF Ventures Inc. "As we embark on building the largest state-of-the-art medical cannabis greenhouse in the southern hemisphere, we are encouraged to see regulators embrace the benefits of medical cannabis.

  • PUF Ventures Inc. - Dr. Cezar Khursigara, PhD Joins PUF Ventures Advisory Board
    CNW Group4 months ago

    PUF Ventures Inc. - Dr. Cezar Khursigara, PhD Joins PUF Ventures Advisory Board

    VANCOUVER , April 23, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (PU3.F) (PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that the Company has appointed  Dr. Cezar Khursigara to its Advisory Board. The Advisory Board will oversee all areas related to PUF Ventures' medical cannabis research and development initiatives.

  • PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.
    CNW Group4 months ago

    PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.

    PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.

  • PUF Ventures Inc. Announces a Plan to Spin Out its Subsidiary Natures Hemp Inc.
    CNW Group4 months ago

    PUF Ventures Inc. Announces a Plan to Spin Out its Subsidiary Natures Hemp Inc.

    PUF Ventures Inc. Announces a Plan to Spin Out its Subsidiary Natures Hemp Inc.

  • PUF Ventures Announces Stock Option Grants
    CNW Group5 months ago

    PUF Ventures Announces Stock Option Grants

    PUF Ventures Announces Stock Option Grants

  • Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture
    CNW Group6 months ago

    Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture

    Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture

  • Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science
    CNW Group6 months ago

    Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science

    Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science

  • CNW Group6 months ago

    Cannvas Medtech Inc. Forms Technology Partnership with Blox Labs for Digital Marketing and Branding

    Cannvas Medtech Inc. Forms Technology Partnership with Blox Labs for Digital Marketing and Branding

  • CNW Group7 months ago

    PUF Ventures to Submit Confirmation of Readiness for Licence Under the ACMPR for London, Ontario Facility

    PUF Ventures to Submit Confirmation of Readiness for Licence Under the ACMPR for London, Ontario Facility

  • PUF Ventures Announces Closing of Plan of Arrangement with Cannvas Medtech Inc.
    CNW Group7 months ago

    PUF Ventures Announces Closing of Plan of Arrangement with Cannvas Medtech Inc.

    PUF Ventures Announces Closing of Plan of Arrangement with Cannvas Medtech Inc.

  • PUF Ventures Inc. - Australia to Allow Exportation of Cannabis Products
    CNW Group7 months ago

    PUF Ventures Inc. - Australia to Allow Exportation of Cannabis Products

    PUF Ventures Inc. - Australia to Allow Exportation of Cannabis Products

  • CNW Group8 months ago

    PUF Ventures Announces Application Acceptance and Name Change of PUF Ventures Australia

    PUF Ventures Announces Application Acceptance and Name Change of PUF Ventures Australia

  • PUF Ventures Australia Files for Medical Research License in Collaboration with Western Sydney University
    CNW Group8 months ago

    PUF Ventures Australia Files for Medical Research License in Collaboration with Western Sydney University

    PUF Ventures Australia Files for Medical Research License in Collaboration with Western Sydney University